Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 26 | 2023 | 3143 | 2.360 |
Why?
|
Kidney Neoplasms | 25 | 2023 | 4262 | 2.060 |
Why?
|
Diagnostic Imaging | 33 | 2019 | 3508 | 1.770 |
Why?
|
Molecular Targeted Therapy | 24 | 2018 | 2725 | 1.730 |
Why?
|
Tomography, X-Ray Computed | 41 | 2023 | 20130 | 0.850 |
Why?
|
Neoplasm Metastasis | 18 | 2019 | 4851 | 0.850 |
Why?
|
Angiogenesis Inhibitors | 8 | 2017 | 2038 | 0.830 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2018 | 3511 | 0.800 |
Why?
|
Radiology | 9 | 2022 | 2099 | 0.800 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 135 | 0.650 |
Why?
|
Muscle Neoplasms | 1 | 2017 | 139 | 0.560 |
Why?
|
Gastrointestinal Stromal Tumors | 8 | 2015 | 643 | 0.550 |
Why?
|
Neoplasms | 19 | 2017 | 21696 | 0.520 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 299 | 0.480 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2017 | 2249 | 0.460 |
Why?
|
Gastrointestinal Neoplasms | 7 | 2015 | 990 | 0.460 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3616 | 0.430 |
Why?
|
Antineoplastic Agents | 18 | 2018 | 13693 | 0.420 |
Why?
|
Soft Tissue Neoplasms | 5 | 2015 | 1363 | 0.420 |
Why?
|
Medical Oncology | 3 | 2019 | 2267 | 0.420 |
Why?
|
Vinblastine | 2 | 2014 | 502 | 0.390 |
Why?
|
Positron-Emission Tomography | 18 | 2016 | 6234 | 0.390 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.390 |
Why?
|
Charcot-Marie-Tooth Disease | 4 | 2008 | 94 | 0.380 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 2291 | 0.370 |
Why?
|
Neoplasm Staging | 15 | 2018 | 11031 | 0.350 |
Why?
|
Urothelium | 1 | 2011 | 277 | 0.350 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1078 | 0.330 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2014 | 808 | 0.320 |
Why?
|
Thromboembolism | 1 | 2014 | 987 | 0.320 |
Why?
|
Colonic Diseases | 1 | 2009 | 202 | 0.310 |
Why?
|
Oncology Service, Hospital | 3 | 2017 | 57 | 0.310 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9274 | 0.300 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2016 | 2020 | 0.280 |
Why?
|
Radiopharmaceuticals | 11 | 2015 | 2645 | 0.280 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2015 | 2016 | 0.280 |
Why?
|
Benzamides | 5 | 2015 | 1379 | 0.280 |
Why?
|
Endosonography | 2 | 2015 | 610 | 0.270 |
Why?
|
Humans | 122 | 2023 | 744366 | 0.270 |
Why?
|
Bone Neoplasms | 6 | 2018 | 2530 | 0.270 |
Why?
|
Curriculum | 2 | 2017 | 3605 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 21 | 2017 | 35425 | 0.260 |
Why?
|
Liver Diseases | 1 | 2014 | 1253 | 0.260 |
Why?
|
Vascular Diseases | 1 | 2014 | 1161 | 0.260 |
Why?
|
Tumor Burden | 1 | 2011 | 1915 | 0.250 |
Why?
|
Skin Neoplasms | 4 | 2021 | 5692 | 0.240 |
Why?
|
Genomics | 2 | 2019 | 5717 | 0.230 |
Why?
|
Liver Neoplasms | 7 | 2017 | 4253 | 0.220 |
Why?
|
Fibromatosis, Aggressive | 2 | 2016 | 118 | 0.220 |
Why?
|
Diagnosis, Differential | 17 | 2017 | 12961 | 0.220 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2016 | 2110 | 0.220 |
Why?
|
Sarcoma | 5 | 2016 | 1897 | 0.220 |
Why?
|
Treatment Outcome | 26 | 2018 | 63107 | 0.220 |
Why?
|
Hemorrhage | 1 | 2014 | 3461 | 0.220 |
Why?
|
Ultrasonography | 3 | 2014 | 5984 | 0.210 |
Why?
|
Pyrimidines | 7 | 2018 | 2943 | 0.200 |
Why?
|
Neuroendocrine Tumors | 3 | 2018 | 594 | 0.200 |
Why?
|
Aged | 49 | 2021 | 163288 | 0.200 |
Why?
|
Piperazines | 5 | 2015 | 2488 | 0.200 |
Why?
|
Middle Aged | 51 | 2021 | 213390 | 0.190 |
Why?
|
Thrombosis | 1 | 2015 | 2968 | 0.190 |
Why?
|
Aged, 80 and over | 27 | 2021 | 57776 | 0.190 |
Why?
|
Pyrroles | 3 | 2013 | 1146 | 0.190 |
Why?
|
von Hippel-Lindau Disease | 1 | 2021 | 152 | 0.180 |
Why?
|
ROC Curve | 3 | 2014 | 3528 | 0.180 |
Why?
|
Hematologic Neoplasms | 5 | 2016 | 1832 | 0.180 |
Why?
|
Lymphoma | 4 | 2014 | 1877 | 0.180 |
Why?
|
Niacinamide | 2 | 2013 | 416 | 0.180 |
Why?
|
Teratoma | 2 | 2014 | 395 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 5 | 2018 | 5534 | 0.180 |
Why?
|
Female | 62 | 2022 | 380193 | 0.180 |
Why?
|
Male | 61 | 2022 | 350115 | 0.170 |
Why?
|
Carcinoid Tumor | 1 | 2021 | 235 | 0.170 |
Why?
|
Esophageal Neoplasms | 3 | 2015 | 1585 | 0.170 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1205 | 0.170 |
Why?
|
Phenylurea Compounds | 2 | 2013 | 528 | 0.170 |
Why?
|
Observer Variation | 4 | 2013 | 2593 | 0.170 |
Why?
|
Edema | 4 | 2015 | 789 | 0.160 |
Why?
|
Indoles | 3 | 2013 | 1839 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2016 | 9240 | 0.160 |
Why?
|
Urogenital Neoplasms | 1 | 2019 | 137 | 0.150 |
Why?
|
Radium | 1 | 2018 | 65 | 0.150 |
Why?
|
Contrast Media | 14 | 2017 | 5300 | 0.150 |
Why?
|
Adult | 40 | 2021 | 214052 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2015 | 4034 | 0.150 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2017 | 32 | 0.150 |
Why?
|
Adenoma, Liver Cell | 1 | 2017 | 33 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5172 | 0.140 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 44 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2012 | 740 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 161 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 2212 | 0.140 |
Why?
|
Pneumatosis Cystoides Intestinalis | 2 | 2012 | 31 | 0.140 |
Why?
|
Osteosarcoma | 2 | 2012 | 881 | 0.140 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6896 | 0.130 |
Why?
|
Intestinal Fistula | 2 | 2013 | 140 | 0.130 |
Why?
|
Pancreatitis | 2 | 2013 | 1092 | 0.130 |
Why?
|
Nerve Degeneration | 1 | 2000 | 748 | 0.130 |
Why?
|
Kidney | 1 | 2011 | 7184 | 0.130 |
Why?
|
Prognosis | 13 | 2017 | 29060 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 2214 | 0.130 |
Why?
|
Retrospective Studies | 22 | 2022 | 77460 | 0.130 |
Why?
|
Cholecystitis | 2 | 2013 | 182 | 0.130 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2017 | 134 | 0.130 |
Why?
|
Hormone Antagonists | 1 | 2015 | 108 | 0.130 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 169 | 0.130 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 350 | 0.130 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 207 | 0.120 |
Why?
|
Neoadjuvant Therapy | 3 | 2014 | 2727 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.120 |
Why?
|
Intestinal Perforation | 2 | 2012 | 253 | 0.120 |
Why?
|
Neural Conduction | 3 | 2008 | 440 | 0.120 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2015 | 233 | 0.120 |
Why?
|
Phlebography | 1 | 2015 | 333 | 0.120 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5263 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1788 | 0.110 |
Why?
|
Vena Cava, Inferior | 2 | 2017 | 440 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2943 | 0.110 |
Why?
|
Protective Agents | 1 | 2014 | 156 | 0.110 |
Why?
|
Peripheral Nerves | 2 | 2008 | 466 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2760 | 0.110 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 125 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2012 | 57 | 0.110 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 59 | 0.110 |
Why?
|
Histiocytic Sarcoma | 1 | 2012 | 44 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 6539 | 0.100 |
Why?
|
Axons | 1 | 2000 | 1685 | 0.100 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2013 | 104 | 0.100 |
Why?
|
Intestine, Small | 2 | 2015 | 1240 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 412 | 0.100 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2011 | 45 | 0.100 |
Why?
|
Drug Therapy | 1 | 2014 | 497 | 0.100 |
Why?
|
Histiocytosis, Sinus | 1 | 2011 | 47 | 0.100 |
Why?
|
Splenic Neoplasms | 1 | 2011 | 100 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 648 | 0.100 |
Why?
|
Problem Solving | 1 | 2014 | 440 | 0.100 |
Why?
|
Hormones | 1 | 2015 | 889 | 0.100 |
Why?
|
Hepatitis | 1 | 2013 | 227 | 0.100 |
Why?
|
Sarcoma, Synovial | 1 | 2012 | 167 | 0.100 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 191 | 0.100 |
Why?
|
Vulvar Neoplasms | 1 | 2013 | 272 | 0.090 |
Why?
|
Peritoneal Neoplasms | 2 | 2015 | 665 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2018 | 11525 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 783 | 0.090 |
Why?
|
Veins | 1 | 2015 | 770 | 0.090 |
Why?
|
Radiography | 7 | 2015 | 7023 | 0.090 |
Why?
|
Thoracic Wall | 1 | 2012 | 203 | 0.090 |
Why?
|
Benzenesulfonates | 1 | 2011 | 169 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 943 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.090 |
Why?
|
Thoracic Neoplasms | 1 | 2012 | 268 | 0.090 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13104 | 0.090 |
Why?
|
Pheochromocytoma | 1 | 2012 | 337 | 0.090 |
Why?
|
Sacrum | 1 | 2011 | 288 | 0.090 |
Why?
|
Enteritis | 1 | 2011 | 165 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2617 | 0.090 |
Why?
|
Pathology, Molecular | 1 | 2013 | 326 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 295 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2012 | 382 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6364 | 0.090 |
Why?
|
Anus Neoplasms | 1 | 2013 | 332 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 545 | 0.090 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2013 | 303 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2011 | 420 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 956 | 0.080 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2012 | 340 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 537 | 0.080 |
Why?
|
Cystectomy | 1 | 2014 | 686 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 501 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 814 | 0.080 |
Why?
|
Chordoma | 1 | 2011 | 359 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5445 | 0.080 |
Why?
|
Liposarcoma | 1 | 2011 | 333 | 0.080 |
Why?
|
Electrodiagnosis | 2 | 2008 | 151 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 520 | 0.080 |
Why?
|
Melanoma | 3 | 2017 | 5511 | 0.080 |
Why?
|
Colitis | 2 | 2013 | 1170 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1520 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2014 | 806 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.080 |
Why?
|
Urologic Neoplasms | 1 | 2011 | 318 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 570 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1332 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2012 | 530 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
Spinal Neoplasms | 1 | 2014 | 760 | 0.070 |
Why?
|
Sirolimus | 2 | 2012 | 1565 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 604 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1524 | 0.070 |
Why?
|
Internship and Residency | 1 | 2007 | 5791 | 0.070 |
Why?
|
Gait Disorders, Neurologic | 1 | 2009 | 231 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3326 | 0.070 |
Why?
|
Image Enhancement | 2 | 2017 | 2921 | 0.070 |
Why?
|
Lymphatic Metastasis | 4 | 2015 | 2924 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2013 | 19905 | 0.070 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 567 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 516 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2850 | 0.070 |
Why?
|
Decision Trees | 2 | 2017 | 506 | 0.060 |
Why?
|
Amyloidosis | 1 | 2012 | 796 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2012 | 934 | 0.060 |
Why?
|
Neutrophils | 1 | 2018 | 3721 | 0.060 |
Why?
|
Connexins | 1 | 2007 | 357 | 0.060 |
Why?
|
Pyridines | 2 | 2021 | 2825 | 0.060 |
Why?
|
Survival Analysis | 4 | 2019 | 10252 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5388 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2014 | 3480 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15078 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 620 | 0.060 |
Why?
|
Indazoles | 2 | 2018 | 290 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3531 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1351 | 0.060 |
Why?
|
Time Factors | 4 | 2015 | 40075 | 0.060 |
Why?
|
Education, Medical | 1 | 2015 | 1722 | 0.060 |
Why?
|
Ascites | 2 | 2015 | 344 | 0.060 |
Why?
|
Pericardial Effusion | 2 | 2015 | 247 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2282 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2012 | 1513 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1636 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 13882 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8861 | 0.050 |
Why?
|
Boston | 2 | 2016 | 9312 | 0.050 |
Why?
|
Pleural Effusion | 2 | 2015 | 337 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14723 | 0.050 |
Why?
|
Phenotype | 3 | 2021 | 16367 | 0.050 |
Why?
|
Disability Evaluation | 2 | 2008 | 1828 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2375 | 0.050 |
Why?
|
Action Potentials | 3 | 2008 | 1806 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.050 |
Why?
|
Gene Silencing | 1 | 2007 | 1539 | 0.050 |
Why?
|
Isometric Contraction | 1 | 2000 | 143 | 0.050 |
Why?
|
Pneumonia | 1 | 2012 | 2133 | 0.050 |
Why?
|
Urogenital System | 1 | 2019 | 86 | 0.040 |
Why?
|
Fluorine Radioisotopes | 2 | 2012 | 442 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 634 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 387 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 408 | 0.040 |
Why?
|
Disease Progression | 5 | 2012 | 13286 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 2031 | 0.040 |
Why?
|
Young Adult | 8 | 2018 | 56429 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 8949 | 0.040 |
Why?
|
Colorectal Neoplasms | 2 | 2015 | 6773 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2375 | 0.040 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 885 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2000 | 506 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 3922 | 0.040 |
Why?
|
Incidental Findings | 2 | 2012 | 689 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2000 | 413 | 0.040 |
Why?
|
Electrophysiology | 1 | 2000 | 1308 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5223 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 382 | 0.040 |
Why?
|
Radioisotopes | 1 | 2018 | 500 | 0.040 |
Why?
|
Mutation | 3 | 2019 | 29786 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2002 | 1158 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.030 |
Why?
|
Sulfonamides | 2 | 2018 | 1940 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2002 | 4925 | 0.030 |
Why?
|
United States | 3 | 2018 | 69872 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 538 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 127 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2000 | 788 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2018 | 575 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 402 | 0.030 |
Why?
|
Filgrastim | 1 | 2014 | 133 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4839 | 0.030 |
Why?
|
Mesenchymoma | 1 | 2014 | 47 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 40559 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 836 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4642 | 0.030 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 101 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.030 |
Why?
|
Cholecystitis, Acute | 1 | 2013 | 70 | 0.030 |
Why?
|
Movement | 1 | 2000 | 1471 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2008 | 931 | 0.030 |
Why?
|
Walking | 1 | 2000 | 1180 | 0.030 |
Why?
|
World Health Organization | 1 | 2018 | 1318 | 0.030 |
Why?
|
Acute Disease | 2 | 2013 | 7147 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7658 | 0.030 |
Why?
|
Fibromatosis, Abdominal | 1 | 2011 | 24 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 574 | 0.030 |
Why?
|
Renal Veins | 1 | 2012 | 108 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1116 | 0.030 |
Why?
|
Gallbladder | 1 | 2013 | 302 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.030 |
Why?
|
Pancreas | 1 | 2018 | 1687 | 0.030 |
Why?
|
Sclerosis | 1 | 2012 | 213 | 0.030 |
Why?
|
Viscera | 1 | 2012 | 139 | 0.030 |
Why?
|
Carcinosarcoma | 1 | 2012 | 108 | 0.030 |
Why?
|
Cholecystectomy | 1 | 2013 | 395 | 0.020 |
Why?
|
Buttocks | 1 | 2011 | 110 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2012 | 2455 | 0.020 |
Why?
|
Endonucleases | 1 | 2014 | 380 | 0.020 |
Why?
|
Echocardiography | 2 | 2015 | 5099 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2017 | 1011 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1758 | 0.020 |
Why?
|
Joints | 1 | 2012 | 327 | 0.020 |
Why?
|
Gastroenteritis | 1 | 2012 | 245 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2012 | 341 | 0.020 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2011 | 129 | 0.020 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 175 | 0.020 |
Why?
|
Ovariectomy | 1 | 2012 | 661 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2012 | 241 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7914 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2385 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12356 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 710 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1182 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11126 | 0.020 |
Why?
|
Esophagectomy | 1 | 2012 | 447 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2013 | 576 | 0.020 |
Why?
|
Leiomyosarcoma | 1 | 2012 | 477 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1662 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2009 | 156 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 924 | 0.020 |
Why?
|
Adolescent | 5 | 2012 | 85779 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2234 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1728 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1660 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 6994 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 141 | 0.020 |
Why?
|
Medical Records | 1 | 2012 | 1413 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1107 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
Prednisone | 1 | 2011 | 1574 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1438 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 927 | 0.020 |
Why?
|
Nephrectomy | 1 | 2012 | 1050 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 727 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1851 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2951 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2576 | 0.020 |
Why?
|
Ulnar Nerve | 1 | 2005 | 106 | 0.020 |
Why?
|
Child | 4 | 2012 | 77709 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 841 | 0.020 |
Why?
|
Median Nerve | 1 | 2005 | 129 | 0.020 |
Why?
|
Ischemia | 1 | 2013 | 1907 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6621 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1062 | 0.010 |
Why?
|
Aging | 1 | 2002 | 8664 | 0.010 |
Why?
|
Outpatients | 1 | 2011 | 1487 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2011 | 1640 | 0.010 |
Why?
|
Child, Preschool | 2 | 2008 | 41005 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2297 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3493 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6755 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2108 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2902 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7475 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39052 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1378 | 0.010 |
Why?
|
Hindlimb | 1 | 2002 | 504 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3309 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3401 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1828 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6566 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4772 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4153 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12244 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4464 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5953 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53290 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2251 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9647 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4446 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 72296 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7282 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13991 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4468 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11486 | 0.010 |
Why?
|
Lung | 1 | 2012 | 9857 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23404 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20952 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10637 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4671 | 0.010 |
Why?
|
Heart Failure | 1 | 2015 | 10895 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12952 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18373 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20824 | 0.010 |
Why?
|
Brain | 1 | 2012 | 26388 | 0.000 |
Why?
|
Mice | 1 | 2002 | 81201 | 0.000 |
Why?
|
Animals | 1 | 2002 | 168768 | 0.000 |
Why?
|